Depression in Parkinson’s disease: an eight- month, randomised, open-label, national, multi-entre comparative study of pramipexole and pergolide

Abstract

The effect of pramipexole and pergolide on motor symptoms, motor complications, cognitive and executive functions of Parkinson disease was studied.